Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FRUF4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,761
Award facts
- Contract value 100% obligated
- $27,760.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,760.68 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This non-set-aside, firm fixed-price delivery order was competitively awarded on September 3, 2025, with an ultimate completion date of September 4, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen leverages its IDC to supply a broad spectrum of pharmaceutical products and medical supplies to support military and veteran healthcare systems. Enbrel is a biologic medication used primarily for rheumatoid arthritis and other autoimmune conditions, and this delivery order represents one of numerous pharmaceutical orders the contractor fulfills through the DLA's medical supply chain. AmerisourceBergen's consistent receipt of competitively awarded contracts across multiple therapeutic domains demonstrates its capability to meet federal procurement standards and support the Department of Defense healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FRUF4?
SPE2DB25FRUF4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FRUF4 worth?
The government has obligated $27,761 on SPE2DB25FRUF4.
Is contract SPE2DB25FRUF4 an order under another contract?
Yes. SPE2DB25FRUF4 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRUF4 competed?
The extent of competition for SPE2DB25FRUF4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award